Skip to main content
. 2012 Oct;56(10):5023–5030. doi: 10.1128/AAC.00057-12

Fig 6.

Fig 6

Time-kill studies of CB-183,315 at 16× the MIC against three strains of C. difficile, including RMA 19139, a NAP1 strain from RM Alden Laboratory, ATCC 43596, a toxigenic clinical isolate, and ATCC 700057, a nontoxigenic strain used for susceptibility testing. MICs against CB-183,315 for these strains were 0.06 μg/ml for the NAP1 strain, 0.06 μg/ml for the toxigenic strain, and 0.25 μg/ml for the nontoxigenic strain. CB-183,315 was bactericidal against all three strains of C. difficile.